ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Cardiovascular Risk, Acute Myocardial Infarction (AMI)
In brief
The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivekimab might reduce development of heart disease, thereby preventing new heart attacks or strokes. Participants will either get ziltivekimab (active medicine) or placebo (a dummy medicine which has no effect on the body). Which treatment participants get is decided by chance. The chance of getting ziltivekimab or placebo is the same. The participant will need to inject the study medicine into a flat skin surface in there stomach, thigh, or upper arm once every month. Ziltivekimab is not yet approved in any country or region in the world. It is a new medicine that doctors cannot prescribe. The study will last for about 2 years.
Key facts
- Study ID
- NCT06118281
- Run by
- Novo Nordisk A/S
- People needed
- 10000
- Starts
- 2024-06-25
- Expected to finish
- 2026-12-14
- Last updated by the study team
- 2026-04-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- "UMHAT "Sveta Anna" Sofia" AD, Clinic of Cardiology — Sofia, Bulgaria (enrolling)
- Sunnybrook Health Sciences Centre — Toronto, Ontario, Canada (enrolling)
- Hospital Español de Mendoza — Godoy Cruz, Mendoza, Mendoza Province, Argentina (enrolling)
- Multiprofile Hospital For Active Treatment Dr. Tota Venkova AD — Gabrovo, Bulgaria (enrolling)
- Royal Victoria Regional Health Centre — Barrie, Ontario, Canada (enrolling)
- Southlake Regional Hlth Centre — Newmarket, Ontario, Canada (enrolling)
- Jacobi Medical Center — The Bronx, New York, United States (enrolling)
- Methodist Healthcare System of San Antonio — San Antonio, Texas, United States (enrolling)
- Royal Adelaide Hospital Cardiovascular Clinical Trials — Adelaide, South Australia, Australia (enrolling)
- PUCCAMP - Hospital e Maternidade Celso Pierro — Campinas, São Paulo, Brazil (enrolling)
- New Brunswick Heart Centre — Saint John, New Brunswick, Canada (enrolling)
- QE II Health Sciences Centre — Halifax, Nova Scotia, Canada (enrolling)
- William Osler Hel Bra Civic Hs — Brampton, Ontario, Canada (enrolling)
- Kingston General Hospital — Kingston, Ontario, Canada (enrolling)
- Winter Haven Hospital — Winter Haven, Florida, United States (enrolling)
- Cardiolg Assoc Rsch LLC_Tupelo — Tupelo, Mississippi, United States (enrolling)
- Trinity Medical Group — Minot, North Dakota, United States (enrolling)
- Chambersburg Hospital — Chambersburg, Pennsylvania, United States (enrolling)
- The Prince Charles Hospital — Brisbane, Queensland, Australia (enrolling)
- Gold Coast University Hosptial — Southport, Queensland, Australia (enrolling)
- Lyell McEwin Hospital — Elizabeth Vale, South Australia, Australia (enrolling)
- Hospital Agamenon Magalhães — Recife, Pernambuco, Brazil (enrolling)
- Specialized Hospital For Active Cardiology Treatement Cardiolife OOD — Varna, Bulgaria (enrolling)
- UMHAT "Sveta Marina" EAD — Varna, Bulgaria (enrolling)
- St. Michael's Hospital — Toronto, Ontario, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.